Virbac SA Valuation
| VRBCF Stock | USD 346.00 0.00 0.00% |
At this time, the company appears to be fairly valued. Virbac SA has a current Real Value of $346.0 per share. The regular price of the company is $346.0. Our model measures the value of Virbac SA from inspecting the company fundamentals such as Operating Margin of 0.16 %, shares outstanding of 8.44 M, and Return On Equity of 0.15 as well as reviewing its technical indicators and probability of bankruptcy.
Fairly Valued
Today
Please note that Virbac SA's price fluctuation is very steady at this time. Calculation of the real value of Virbac SA is based on 3 months time horizon. Increasing Virbac SA's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Virbac pink sheet is determined by what a typical buyer is willing to pay for full or partial control of Virbac SA. Since Virbac SA is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Virbac Pink Sheet. However, Virbac SA's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 346.0 | Real 346.0 | Hype 346.0 |
The real value of Virbac Pink Sheet, also known as its intrinsic value, is the underlying worth of Virbac SA Company, which is reflected in its stock price. It is based on Virbac SA's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Virbac SA's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Virbac SA helps investors to forecast how Virbac pink sheet's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Virbac SA more accurately as focusing exclusively on Virbac SA's fundamentals will not take into account other important factors: About Virbac SA Valuation
The pink sheet valuation mechanism determines Virbac SA's current worth on a weekly basis. Our valuation model uses a comparative analysis of Virbac SA. We calculate exposure to Virbac SA's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Virbac SA's related companies.Virbac SA manufactures and sells a range of products and services for companion and food-producing animals in France, Europe, Latin America, North America, the Asia Pacific, the Middle East, and Africa. Virbac SA was founded in 1968 and is headquartered in Carros, France. Virbac Sa operates under Drug ManufacturersGeneral classification in the United States and is traded on OTC Exchange. It employs 5120 people.
8 Steps to conduct Virbac SA's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Virbac SA's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Virbac SA's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Virbac SA's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Virbac SA's revenue streams: Identify Virbac SA's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Virbac SA's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Virbac SA's growth potential: Evaluate Virbac SA's management, business model, and growth potential.
- Determine Virbac SA's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Virbac SA's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Virbac SA Growth Indicators
Investing in growth stocks can be very risky. If the company such as Virbac SA does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 8.4 M | |
| Quarterly Earnings Growth Y O Y | 0.076 | |
| Retained Earnings | 114.3 M |
Complementary Tools for Virbac Pink Sheet analysis
When running Virbac SA's price analysis, check to measure Virbac SA's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Virbac SA is operating at the current time. Most of Virbac SA's value examination focuses on studying past and present price action to predict the probability of Virbac SA's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Virbac SA's price. Additionally, you may evaluate how the addition of Virbac SA to your portfolios can decrease your overall portfolio volatility.
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators |